Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04793737 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases

Study acronym: PROMMEL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 5, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. 3 versions Re-verified since Aug 16, 2022, no change to tracked fieldsv2-v4
  2. Study First Submitted
To evaluate tumor response, survival and adverse effects after precision radiotherapy (SBRT) in melanoma patients with ongoing PD-1 inhibitor treatment that have tumor progression.
Trial Details
NCT Number NCT04793737
Lead Sponsor Karolinska University Hospital
Conditions
(from sponsor)		 Metastatic Melanoma
Related terms Melanoma
Enrollment 27 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov